Chromatin disruptions in pathophysiologically relevant gene promoters underlie unique SARS-Cov-2 nucleocapsid-mediated gene regulation
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 48 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 48 samples: 48 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE290042_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1226091 and SRA study SRP565631. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 48 sample titles: 48 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8804273 A549_HKU1_nucleocapsid_rep1_merged
- GSM8804274 A549_HKU1_nucleocapsid_rep2_merged
- GSM8804275 A549_229E_nucleocapsid_rep1_merged
- GSM8804276 A549_229E_nucleocapsid_rep2_merged
- GSM8804277 A549_OC43_nucleocapsid_rep1_merged
- GSM8804278 A549_OC43_nucleocapsid_rep2_merged
- GSM8804279 A549_NL63_nucleocapsid_rep1_merged
- GSM8804280 A549_NL63_nucleocapsid_rep2_merged
- GSM8804281 A549_null_nucleocapsid_rep1_merged
- GSM8804282 A549_null_nucleocapsid_rep2_merged
- GSM8804283 A549_MERS_nucleocapsid_rep1_merged
- GSM8804284 A549_MERS_nucleocapsid_rep2_merged
- GSM8804285 A549_SARS1_nucleocapsid_rep1_merged
- GSM8804286 A549_SARS1_nucleocapsid_rep2_merged
- GSM8804287 A549_SARS2_nucleocapsid_rep1_merged
- GSM8804288 A549_SARS2_nucleocapsid_rep2_merged
- GSM8804289 A549_HKU1_nucleocapsid_rep1_light_digest
- GSM8804290 A549_HKU1_nucleocapsid_rep2_light_digest
- GSM8804291 A549_229E_nucleocapsid_rep1_light_digest
- GSM8804292 A549_229E_nucleocapsid_rep2_light_digest
- GSM8804293 A549_OC43_nucleocapsid_rep1_light_digest
- GSM8804294 A549_OC43_nucleocapsid_rep2_light_digest
- GSM8804295 A549_NL63_nucleocapsid_rep1_light_digest
- GSM8804296 A549_NL63_nucleocapsid_rep2_light_digest
- GSM8804297 A549_null_nucleocapsid_rep1_light_digest
- GSM8804298 A549_null_nucleocapsid_rep2_light_digest
- GSM8804299 A549_MERS_nucleocapsid_rep1_light_digest
- GSM8804300 A549_MERS_nucleocapsid_rep2_light_digest
- GSM8804301 A549_SARS1_nucleocapsid_rep1_light_digest
- GSM8804302 A549_SARS1_nucleocapsid_rep2_light_digest
- GSM8804303 A549_SARS2_nucleocapsid_rep1_light_digest
- GSM8804304 A549_SARS2_nucleocapsid_rep2_light_digest
- GSM8804305 A549_HKU1_nucleocapsid_rep1_heavy_digest
- GSM8804306 A549_HKU1_nucleocapsid_rep2_heavy_digest
- GSM8804307 A549_229E_nucleocapsid_rep1_heavy_digest
- GSM8804308 A549_229E_nucleocapsid_rep2_heavy_digest
- GSM8804309 A549_OC43_nucleocapsid_rep1_heavy_digest
- GSM8804310 A549_OC43_nucleocapsid_rep2_heavy_digest
- GSM8804311 A549_NL63_nucleocapsid_rep1_heavy_digest
- GSM8804312 A549_NL63_nucleocapsid_rep2_heavy_digest
+ 8 more — browse all 48 samples with per-sample file links →
- GSE272756 SARS-CoV-2 infection of human lung ALI cultures reveals basal cells as relevant targets 54 samples shares sars-cov-2, relevant
- GSE206605 IMMUNE DYSREGULATION FOLLOWING INFECTION BY THE NEW CORONAVIRUS SARS-CoV-2 (COVID-19); A NEW DISEASE ENTITY 24 samples shares sars-cov-2
- GSE210231 CD8+ T cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by shifts in clonal dominance 931 samples shares sars-cov-2
- GSE276544 MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity 305 samples shares sars-cov-2
- GSE325454 Mitochondrial OXPHOS restricts SARS-CoV-2 replication 148 samples shares sars-cov-2
- GSE288346 Multi-Omics Analysis of the Immunological State at Baseline and Following SARS-CoV-2 mRNA Vaccination in Lung Transplant Recipients [RNA-seq] 106 samples shares sars-cov-2
- GSE289648 Maternal acute SARS-CoV-2 infection impairs preimplantation embryo development and reprograms early offspring hematopoietic system 102 samples shares sars-cov-2
- GSE303984 Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vaccines 102 samples shares sars-cov-2
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.